Article ID Journal Published Year Pages File Type
1922624 Parkinsonism & Related Disorders 2007 4 Pages PDF
Abstract

Chronic high-frequency stimulation of the subthalamic nucleus has evolved into a routine treatment for motor fluctuations, dyskinesia and medically refractory tremor in Parkinson's disease. The most important predictors for surgical benefit include excellent responsiveness of akinetic-rigid and axial motor symptoms to levodopa, a normal cognitive status and younger age. Current evidence suggests that for patients fulfilling these selection criteria deep brain stimulation of the subthalamic nucleus is superior to standard oral drug therapy in maintaining a good level of health-related quality of life.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Ageing
Authors
,